Medical device manufacturer AP Technologies bags investment from AGIC Capital

AGIC Capital, the notable European-Asian private equity firm handling $2.2 billion in assets, has sealed an investment deal with AP Technologies, a rising medical device contract manufacturer. While the exact investment figures remain undisclosed, this collaboration underscores AP Tech’s robust offerings in advanced medical extrusion and catheter assembly processes.

AP Technologies: A Pioneer in Medical Tubing and Catheter Manufacturing

Initiated in 2013, AP Technologies stands at the forefront of medical tubing and catheter contract manufacturing. Their expertise extends to designing, innovating, and producing intricate medical extrusions and interventional catheters. The company’s distinguished clientele comprises blue-chip customers involved in diagnostics, interventional cardiology, neurology, and diabetic care. As the global demand surges for diagnostic and therapeutic solutions, particularly in Asia, AP Technologies is strategically positioned to capture this growth.

AGIC Capital’s Evolving Investment Strategy

This recent investment in AP Technologies is significant for AGIC Capital as it denotes their inaugural transaction in Asia through Fund II. It serves as a pivotal indicator of AGIC’s ongoing development and its broadening geographic focus, reinforcing its commitment along the Europe-Asia axis.

Charles Tang, the CEO and Co-Founder of AP Technologies, expressed his enthusiasm, stating, “We are thrilled to be partnering with AGIC as a leading life science investor to further grow our core business in medical tubing and catheter manufacturing. Their support will allow us to make key investments in enhancing our technological capabilities, while helping us to accelerate our global development strategy. We look forward to the next steps of a successful journey with the AGIC team.”

Further echoing the sentiment, Ken He, a Director at AGIC Capital, elaborated, “We are very impressed with AP’s strong technical capabilities, focus on product quality, and proven track record in working with world-class customers… We look forward to contributing our capital and life science expertise to AP’s growth and expansion.”